Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from China Medical System Holdings ( (HK:0867) ) is now available.
China Medical System Holdings has scheduled a board meeting for 16 March 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ended 31 December 2025. The board will also consider the payment of a final dividend, signaling a potential cash return to shareholders subject to the board’s deliberation and approval.
The timing of the meeting indicates the company is moving toward finalizing its 2025 financial reporting, a key milestone for investors tracking its operational performance and capital allocation. Any decision on a final dividend will be closely watched by the market as an indicator of profitability, balance sheet strength and management’s confidence in the company’s future cash flows.
The most recent analyst rating on (HK:0867) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on China Medical System Holdings stock, see the HK:0867 Stock Forecast page.
More about China Medical System Holdings
China Medical System Holdings is a Hong Kong-listed pharmaceutical company engaged in the development, marketing and distribution of medical products through its subsidiaries. The group focuses on providing prescription drugs and related medical solutions in the Chinese healthcare market, operating under a board led by chairman Lam Kong alongside executive and independent non-executive directors.
Average Trading Volume: 3,973,749
Technical Sentiment Signal: Buy
Current Market Cap: HK$34.54B
For an in-depth examination of 0867 stock, go to TipRanks’ Overview page.